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Confirmation of a gene locus for medullary cystic kidney dis- fects of renal tubules, which result in a reduction in urine
ease (MCKD2) on chromosome 16p12 concentrating ability. The disease typically presents in
Background. Autosomal-dominant medullary cystic kidney young or middle adulthood and usually progresses to end-disease (MCKD) is an interstitial nephropathy characterized
stage renal disease (ESRD) before the age of 65. Hyper-by structural renal tubular defects that result in salt wasting and
tension is common, but patients may become hypotensivea reduction in urinary concentration. The condition has clinical
and morphological similarities to autosomal-recessive juvenile due to excessive salt loss. Hyperuricemia and gout are
nephronophthisis. Two genes predisposing to MCKD have associated features in some families. Ultrasonography
been localized. MCKD1 on chromosome 1q21 was localized
or computed tomography (CT) scanning shows smallin two Cypriot families, and MCKD2 on chromosome 16p12
kidneys with occasional cysts in the medulla or at thewas localized in a single Italian family. We have evaluated a
large Welsh MCKD family for linkage at these two loci. corticomedullary junction. Tubulointerstitial fibrosis and
Methods. Clinical data and DNA samples were collected thickening of the tubular basement membrane are prom-
from affected family members. Polymorphic microsatellite mark- inent histopathological features, but neither is specificers spanning the critical regions on chromosome 1 and chromo-
for MCKD. Cortical thinning and glomerulosclerosis aresome 16 that encompass MCKD1 and MCKD2 were analyzed.
often seen, but there are no pathognomonic findings onTwo-point and multipoint LOD scores were calculated.
Results. The family fulfilled previously published criteria for renal biopsy.
the diagnosis of MCKD, but hyperuricemia and gout were Medullary cystic kidney disease has many clinical and
not prominent features. Twenty-one affected individuals were morphological similarities to familial nephronophthisisidentified. Mean age at death or end-stage renal disease was
(NPH), and the two conditions have been referred to as47 years (37 to 60). Linkage and haplotype analysis generated
strongly negative results at MCKD1 on chromosome 1q21 the NPH/medullary cystic disease complex [1]. Three
(two-point LOD score  5.32). Strong evidence of linkage forms of NPH are classified according to age at onset
to MCKD2 was generated with a maximum multi-point LOD [2]. NPH1 (MIM 256100) is the juvenile-onset form. Mu-
score of 3.75.
tations of the NPHP1 gene at chromosome 2q13 appearConclusion. These results provide the first independent con-
to be responsible for the majority (85%) of the purelyfirmation of a gene predisposing to MCKD on chromosome
16p12 and indicate that mutation of this gene is not restricted renal forms of juvenile NPH, with 65 to 75% of NPH1
to a single family or population. The absence of hyperuricemia patients exhibiting large homozygous deletions of ap-
and gout in our family indicates that these are not obligatory proximately 250 kb encompassing NPHP1 [3, 4]. A mi-features of MCKD2 mutations.
nority of children with classic juvenile NPH appear to
be due to genes other than NPHP1 [5]. An infantile-
Autosomal-dominant medullary cystic kidney disease onset form of NPH also exists (NPH2, MIM 602088),
(MCKD; MIM 174000 and 603860) is a hereditary inter- and a gene predisposing to NPH2 has been localized to
stitial nephropathy that is characterized by structural de- chromosome 9q22-q31 in a single Bedouin family [6]. A
third, adolescence-onset form (NPH3, MIM 604387) has
recently been linked to chromosome 3q22 [7].Key words: familial nephropathy, interstitial nephritis, hyperuricemia,
progressive renal disease. Although MCKD and NPH share morphological fea-
tures, they differ in several important respects. MCKDReceived for publication February 13, 2001
is an adult-onset disease inherited as an autosomal-domi-and in revised form May 8, 2001
Accepted for publication May 10, 2001 nant trait, whereas NPH presents in childhood, and in-
heritance is autosomal recessive. The clinical features of 2001 by the International Society of Nephrology
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the conditions also differ, with polydipsia and polyuria ers that span the intervals encompassing MCKD1 and
being prominent features of NPH, but only rarely present MCKD2 were analyzed. The order and distance between
in MCKD. The NPHP1 gene has been excluded as the markers was obtained from the Marshfield database (http:
predisposition gene in several MCKD families [8, 9]. //research.marshfieldclinic.org/genetics/). For MCKD1,
In 1998, a gene predisposing to autosomal-dominant the order and approximate distance between the markers
medullary cystic disease, MCKD1 (MIM 174000), was is centromere - D1S534 - 3 cM - D1S442 - 5 cM - D1S305 -
localized to chromosome 1q21 in two Cypriot families 2 cM - D1S1595 - 0 cM - D1S2721 - 2 cM - D1S2125 -
with MCKD, hyperuricemia, and gout. The two families 7 cM - D1S1679 - telomere. For MCKD2, the order and
share a haplotype of segregating alleles, suggesting that distance between markers is telomere - D16S405 - 1.5
a single founder mutation is responsible for the pheno- cM - D16S764 - 2 cM - D16S3017 - 1 cM - D16S499 - 0 cM -
type in both families [10]. MCKD1 was subsequently ex- D16S668 - 4.5 cM - D16S3036 - 0 cM - D16S749 - 3.5
cluded in other families, indicating genetic heterogeneity cM - D16S412 - 1 cM - D16S417 - 0.5 cM - D16S420 -
in the predisposition to MCKD [11]. A second locus, 1 cM - D16S3113 -2.5 cM - D16S3068 - 2 cM - D16S769 -
MCKD2 (MIM 603860), on chromosome 16p12 was re- centromere.
ported in a single Italian family with MCKD, hyperuri- Fluorescent-labeled markers were PCR amplified and
cemia, and gout [12]. MCKD families showing evidence electrophoresed through 4.5% polyacrylamide denatur-
against linkage to MCKD1 and MCKD2 have been re- ing gels on an ABI377 sequencer. Genotyping data were
ported, suggesting the existence of at least one further analyzed using GENESCAN and GENOTYPER soft-
MCKD gene [13]. Independent confirmation of the loca- ware.
tions of MCKD1 and MCKD2 in other families thus far
has not been reported. We have evaluated a large Welsh Linkage analysis
MCKD family, previously described by Coles et al, for Medullary cystic kidney disease was modeled as an
linkage to MCKD1 and MCKD2 [14]. autosomal-dominant trait with 90% penetrance by 55
years. A disease gene frequency of 1:10,000 was assumed.
Marker allele frequencies were either assigned using dataMETHODS
from the Marshfield database (http://research.marshfieldFamily and clinical evaluation
clinic.org/genetics) or were estimated from unrelated in-
The four-generation Welsh family includes 21 affected dividuals from the pedigree. Two-point and multipoint
family members (12 women and 9 men; Fig. 1). Permis-
LOD scores were calculated using VITESSE 2.0 beta.sion for the study was granted by the local research ethics
committee, and informed consent was obtained from all
participants. The age at diagnosis, the age at onset of RESULTS
ESRD, and the presence of any of the following compli- Clinical data
cations were recorded: hypertension (WHO criteria,
Evaluation of the clinical and radiological data estab-160 mm Hg systolic and 95 mm Hg diastolic pres-
lished that the Welsh family fulfilled all of the diagnosticsure), proteinuria (urine total protein 300 mg/24 h),
criteria for MCKD. All 21 affected family members arehigh specific urinary gravity, hyperuricemia (serum urate
known to have developed ESRD. The mean age of onset0.42 mmol/L), or gout. Age and cause of death were
of ESRD in this family was 47 years, and the medianavailable in deceased family members (Table 1). Radio-
age was 43 years (37 to 60). Nine individuals died fromlogical investigations, such as renal ultrasonography and
uremia. The remaining 12 family members were treatedCT scanning, were reviewed for the presence of medul-
with some form of renal replacement therapy, and 9 havelary cysts. For patients who had undergone a renal
undergone renal transplantation. All six living affectedbiopsy, the histological data were reviewed (Table 2).
family members have functioning grafts. Postmortem ex-We used the diagnostic criteria proposed by Scolari et al:
aminations were performed on seven affected individu-(1) autosomal-dominant inheritance; (2) defective urine
als, and histological data were available on four of these.concentration with polyuria, isosthenuria, and relatively
All postmortem examinations showed small scarred kid-normal urinalysis results; (3) normal or small-sized kid-
neys with chronic interstitial nephritis or interstitial fi-neys with occasional small medullary cysts; (4) renal
brosis. Additional findings included hypertensive neph-histologic findings characterized by tubulointerstitial fi-
rosclerosis, glomerular sclerosis, and tubular atrophy.brosis with infiltrates, tubular atrophy, and thickening
Cysts were detected in three postmortem specimens. Di-of the tubular basement membrane with periodic Schiff-
agnostic renal biopsies were performed in four patients.positive material [12].
The findings were similar to the postmortem results with
DNA analysis focal tubular atrophy and interstitial fibrosis as the main
features. Glomerular sclerosis, periglomerular fibrosis,DNA was extracted from a 10 mL venous blood sam-
ple by standard methods. Polymorphic microsatellite mark- glomerular enlargement, and tubular dilation were also
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Fig. 1. Pedigree of the Welsh medullary cystic kidney disease (MCKD) family with haplotypes at chromosome 16p12. The closed symbol indicates
individual with MCKD. The underlined number beneath the symbol is the identifier and corresponds to the ID numbers in Tables 1 and 2. The
black bar next to the marker haplotypes indicates the alleles that segregate with MCKD in the family. Data from unaffected individuals who are
potential gene carriers have been omitted to preserve confidentiality.
Table 1. Clinical features and age at end-stage renal disease (ESRD) in Welsh medullary cystic kidney disease (MCKD) family
Age at presentation Age at ESRD/death
ID Presenting clinical features years
1 Chronic renal failure disease 58 Died at 58
2 Uremia and proteinuria 51 Died at 51
3 Hypertension, proteinuria and uremia
4 Hypertension, proteinuria, anemia and uremia 58 Died at 58
5 Hypertension, angina and uremia Died at 53
6 Hypertension, proteinuria and uremia Died at 37
7 Hypertension and proteinuria Died at 37
8 Hypertension and proteinuria ESRD at 46
9 Proteinuria, anemia and uremia 40 ESRD at 43
10 Hypertension and anemia 39 Died after transplant at 43
11 Hypertension, proteinuria and uremia ESRD at 42
12 Hypertension 59 ESRD at 60
13 Hypertension and proteinuria 38 ESRD at 43
14 No data available Died after transplant at 41
15 No data available ESRD at 42
16 No data available ESRD at 37
17 Hypertension 36 ESRD at 37
18 Hypertension ESRD at 56
19 Hypertension 25 ESRD at 51
20 Hypertension 49 ESRD at 52
21 Hypertension 42
In all cases, proteinuria was low grade.
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Table 2. Renal histopathological features in Welsh MCKD family
ID Sample Glomeruli Tubules-interstitiuma Vessels Microcysts
5 Post-mortem 80% global sclerosis, remainder Extensive atrophy and inter- Intimal hyperplasia None
show ischemic damage stitial fibrosis, mild diffuse
chronic inflammation
6 Post-mortem 60% global sclerosis, some seg- Extensive atrophy, focal No specific features Numerous, especially at
mental sclerosis, remainder inflammation corticomedullary junction
ischemic contraction
7 Post-mortem 30% global sclerosis, 70% ischemic Extensive atrophy, mild diffuse No specific features Numerous, near medulla
damage, contraction and chronic inflammation
periglomerular fibrosis
12 Biopsy No glomerular sclerosis, mild Little atrophy, occasional Moderate elastic Occasional
glomerular enlargement dilated tubules reduplication
15 Post-mortem Extensive glomerular sclerosis Diffuse atrophy, interstitial Mild elastic Occasional
fibrosis, mild diffuse chronic reduplication
inflammation
16 Biopsy 30% global sclerosis, 50% Diffuse atrophy, moderate Moderate elastic Occasional
periglomerular fibrosis diffuse chronic inflammation, reduplication, arte-
interstitial fibrosis riolar hyalinization
20 Biopsy No glomeruli present Atrophy and fibrosis None present Occasional
21 Biopsy 50% global sclerosis Bands of atrophy Moderate elastic None
reduplication
a In all cases atrophic tubules showed some basement membrane hyaline thickening; this was not extensive and was in proportion to the degree of atrophy and
was not specific for MCKD.
Table 3. Two-point LOD scores at MCKD1 and MCKD2observed. Occasional microcysts were seen in three biop-
in a Welsh MCKD family
sies. One patient (ID 18), who is alive with a functioning
2-point LOD score at  graft, recently underwent an ultrasound scan, which
0.00 0.05 0.1 0.2 0.3 0.4showed two small native kidneys with multiple small
cysts bilaterally. Hypertension was a prominent feature in MCKD1
D1S534 5.85 1.21 0.69 0.26 0.09 0.0215 of the 18 cases with available clinical data. No individ-
D1S442 3.28 1.23 0.84 0.39 0.15 0.04ual had hyperuricemia or gout. D1S305 2.12 0.12 0.24 0.21 0.11 0.04
The pedigree of the family is shown in Figure 1, and D1S1595 5.44 1.47 0.90 0.38 0.15 0.04
D1S2721 2.31 0.67 0.39 0.14 0.04 0.00the clinical data are summarized in Table 1. Histological
D1S2125 3.46 0.82 0.43 0.15 0.06 0.02data are shown in Table 2. D1S1679 6.20 1.50 0.85 0.31 0.10 0.03
MCKD2
Linkage analysis D16S405 2.12 0.24 0.04 0.07 0.06 0.03
D16S764 2.08 0.34 0.11 0.04 0.06 0.04Eleven individuals were analyzed. This included six D16S3017 2.25 0.02 0.14 0.16 0.09 0.01
affected individuals, two unaffected spouses who were D16S499 3.57 3.24 2.91 2.18 1.40 0.58
D16S668 1.72 1.50 1.28 0.85 0.44 0.13analyzed to provide information about the phase of
D16S3036 2.77 2.49 2.20 1.59 0.96 0.36alleles, and three at-risk individuals who were over 55 D16S749 1.70 1.56 1.39 1.00 0.57 0.19
years. The three at-risk individuals had normal values D16S412 1.50 1.35 1.20 0.88 0.57 0.27
D16S417 1.27 1.09 0.92 0.59 0.30 0.10for blood pressure, serum biochemistry, serum uric acid,
D16S420 4.61 0.72 0.79 0.62 0.35 0.13
creatinine clearance, renal ultrasound, urine microscopy, D16S3113 4.54 0.62 0.82 0.77 0.49 0.18
D16S3068 1.82 0.78 0.89 0.75 0.46 0.16and urine cytology. Two-point LOD scores were nega-
D16S769 1.99 0.46 0.26 0.09 0.02 0.00tive at MCKD1 and positive at MCKD2 (Table 3). Hap-
lotype analysis demonstrates a haplotype of marker al-
leles segregating with the disease at MCKD2 (Fig. 1).
The maximum multipoint LOD score at MCKD2 was
ease complex share virtually identical renal histology.3.75, in the interval between D16S3017 and D16S417
However, the clinical, genetic and molecular characteris-(Fig. 2). Critical meiotic recombinants place MCKD2 in
tics of individuals with this histological phenotype arethe 10 cM interval between D16S3017 and D16S420.
diverse. Both autosomal-dominant and autosomal-reces-
sive forms of the condition are recognized [2]. The au-
DISCUSSION tosomal-recessive forms tend to present in childhood.
The majority of cases are due to deletion of the NPHP1In recent years, considerable insight has been gained
gene on chromosome 2q13 [3]. Genes for infantile NPHinto the genetics of renal disorders characterized by med-
ullary cysts. Diseases of the NPH/medullary cystic dis- and adolescent NPH have been localized to chromosome
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Fig. 2. Multipoint LOD score at MCKD2.
9q22-q31 and chromosome 3q22, respectively, in single instructive. The histopathological features of the families
are very similar. Medullary cysts are identifiable in onlyfamilies [6, 7].
Autosomal-dominant forms of medullary cystic disease a minority of affected individuals in MCKD pedigrees.
In fact, infiltration of the interstitium by chronic inflam-tend to present in adulthood. Two genes predisposing
to autosomal-dominant MCKD, MCKD1 and MCKD2, matory cells leading to interstitial fibrosis is a more uni-
versal feature of MCKD. The previously used term “fa-have been localized. The MCKD1 gene was localized
to chromosome 1q21 in two Cypriot families [10]. The milial interstitial nephritis” [14] seems to reflect more
accurately the pathophysiology associated with this con-MCKD2 gene was localized to chromosome 16p12 in a
single large Italian family [12]. Our results provide the dition.
The age and mode of presentation in the MCKD familiesfirst independent confirmation for the existence of gene
predisposing to MCKD on chromosome 16p12. We have differ somewhat. In the Italian family linked to MCKD2,
presentation was typically between 16 to 30 years. Onlyalso refined the interval encompassing the gene to the
10 cM region between D16S3017 and D16S420. Within four individuals have developed ESRD (at ages 33, 41,
45, and 63 years), although those without ESRD arethis interval are a number of possible candidate genes.
These include the gene encoding uromodulin, which is currently all under 40 years. Individuals came to medical
attention either due to gout or hypertension [8]. In theinvolved in ion transport and the maintenance of water
impermeability [15], the sodium-permeable non-volt- Welsh family, also linked to MCKD2, presentation is
with the features of chronic renal failure or ESRD andage–sensitive ion channels, SCNN1B and SCNN1G [16],
and the rat hypertension homologues SA and KS [17, 18]. occurs between the ages of 30 to 57 years (mean 47
years). In the Cypriot families linked to MCKD1, ESRDExamination of the phenotypes of MCKD families is
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occurred at a mean age of 62 and 55 years in the two fibrosis, thickening of the tubular basement membrane,
families. The age at diagnosis and mode of presentation and even medullary cysts are seen in many other renal
were not stated [10]. conditions. Cysts in the medulla or at the corticomedullary
The most striking phenotypic difference between the junction are often difficult to detect because of their small
families is the absence of hyperuricemia and gout in the size [22, 23]. Imaging by thin-section CT or magnetic
Welsh family. Hyperuricemia and gout were prominent resonance imaging scanning may improve the detection
in several members of both the Italian family linked to rate [24, 25], but it is probable that cysts will only be
MCKD2 and the Cypriot families linked to MCKD1. detectable microscopically in some individuals. The ab-
Gout in these families is most likely related to an im- sence of specific clinical and morphological features is likely
paired net elimination of uric acid by the kidney and it to result in an underascertainment of cases of MCKD,
is possible that the proteins encoded by MCKD1 and particularly in smaller families, or in individuals without
MCKD2 have functioning roles in uric acid excretion. a family history. Identification and characterization of
However, the absence of hyperuricemia and gout in the the MCKD genes will allow more accurate estimation
Welsh family indicate that these are not obligatory fea- of the incidence of the condition and will help to clarify
tures of MCKD or indeed of MCKD2 mutations. the pathophysiological basis of MCKD. Moreover, eluci-
Recently, susceptibility genes for two phenotypes that dation of the pathogenesis of MCKD may provide im-
are similar to MCKD have been localized to the MCKD2 portant insights into the mechanisms of chronic intersti-
and MCKD1 intervals. A gene for familial juvenile hyp- tial nephritis associated with other renal disorders.
eruricemic nephropathy (FJHN, MIM 162000) has been
localized to the identical interval encompassing MCKD2 ACKNOWLEDGMENTS
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